Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listAgomelatine

Agomelatine

Synonym(s):N-[2-(7-Methoxy-1-naphthalenyl)ethyl]-acetamide;S-20098

  • CAS NO.:138112-76-2
  • Empirical Formula: C15H17NO2
  • Molecular Weight: 243.3
  • MDL number: MFCD00916659
  • EINECS: 629-727-7
  • SAFETY DATA SHEET (SDS)
  • Update Date: 2024-11-19 23:02:33
Agomelatine Structural

What is Agomelatine?

Absorption

Bioavailability is less than 5%.

Description

Agomelatine is an agonist of melatonin (MT) receptors and a derivative of melatonin . It binds to MT1 and MT2 receptors (Kis = 0.14 and 0.41 nM, respectively) and has an EC50 value of 0.1 nM in a [35S]GTPγS binding assay using CHO cells expressing MT2 receptors. Agomelatine is also an antagonist of the serotonin (5-HT) receptor subtypes 5-HT2B and 5-HT2C (Kis = 0.26 and 0.71 nM, respectively, for the human receptors). Agomelatine (40 mg/kg) inhibits the penile erection response induced by the 5-HT2 agonist Ro 60-0175 in rats. It also increases extracellular levels of noradrenaline and dopamine in the frontal cortex of freely moving rats when administered at doses ranging from 20 to 80 mg/kg. Agomelatine (10 mg/kg) reduces immobility time in the forced swim test and increases the amount of time spent in the open arms of the elevated plus maze in mice, indicating antidepressant-like and anxiolytic-like activity, in a transgenic neuroendocrine model of depression. It also increases the rate of readjustment to circadian activity cycles following an induced phase shift.

Chemical properties

White Solid

The Uses of Agomelatine

Agomelatine is an antidepressant drug. It is classified as a norepinephrine-dopamine disinhibitor (NDDI) due to its antagonism of the 5-HT2C receptor. Activation of 5-HT2C receptors by serotonin inhibits dopamine and norepinephrine release. Antagonism of

The Uses of Agomelatine

Agomelatine is a melatoninergic agonist and selective antagonist of 5-HT2C receptors, and has been shown to be active in several animal models of depression. Agomelatine (S20098) displayed pKi values of 6.4 and 6.2 at native (porcine) and cloned, human (h)5-hydroxytryptamine (5-HT)2C receptors, respectively.

The Uses of Agomelatine

Agomelatine has been used:

  • to study its effects on adult neurogenesis and hippocampus apoptosis using the stress-induced depression model of rats
  • to explore its effects on tau protein phosphorylation and to study its neuroprotective mechanism
  • to study its effects on intracellular calcium ([Ca2+]i) signaling in peripheral neurons of rat dorsal root ganglion (DRG) neurons

What are the applications of Application

Agomelatine is a melatoninergic agonist of the 5-HT2C receptor

Indications

Agomelatine is indicated to treat major depressive episodes in adults.

Background

Agomelatine is structurally closely related to melatonin. Agomelatine is a potent agonist at melatonin receptors and an antagonist at serotonin-2C (5-HT2C) receptors, tested in an animal model of depression. Agomelatine was developed in Europe by Servier Laboratories Ltd. and submitted to the European Medicines Agency (EMA) in 2005. The Committee for Medical Products for Human Use (CHMP) recommended refusal of marketing authorization on 27 July 2006. The major concern was that efficacy had not been sufficiently shown. In 2006 Servier sold the rights to develop Agomelatine in the US to Novartis.
The development for the US market was discontinued in October 2011. It is currently sold in Australia under the Valdoxan trade name.

Definition

ChEBI: Agomelatine is a member of acetamides.

Biochem/physiol Actions

Agomelatine is an extremely potent agonist at both melatonin receptors (MT1 and MT2), with additional antagonism at 5HT2C. It is a novel antidepressant with many desired in vivo properties, including neuroprotection and neurogenesis in depression-sensitive brain areas. Agomelatine′s efficacy appears to be due to both melatonergic and serotonergic properties. In neurogenesis assays, both in vitro and in vivo, the compound effects were differentially affected by antagonists for MT1/MT2 and 5HT2C, demonstrating actions through all three receptors.

Pharmacokinetics

Agomelatine resynchronises circadian rhythms in animal models of delayed sleep phase syndrome and other circadian rhythm disruptions. It increases noradrenaline and dopamine release specifically in the frontal cortex and has no influence on the extracellular levels of serotonin. Agomelatine has shown an antidepressant-like effect in animal depression models, (learned helplessness test, despair test, and chronic mild stress) circadian rhythm desynchronisation, and in stress and anxiety models. In humans, agomelatine has positive phase shifting properties; it induces a phase advance of sleep, body temperature decline and melatonin onset. Controlled studies in humans have shown that agomelatine is as effective as the SSRI antidepressants paroxetine and sertraline in the treatment of major depression

Clinical Use

Antidepressant

Drug interactions

Potentially hazardous interactions with other drugs
Antibacterials: avoid with ciprofloxacin.
Antidepressants: metabolism inhibited by fluvoxamine.
Antimalarials: avoid with artemether with lumefantrine and artenimol with piperaquine.

Metabolism

Hepatic (90% CYP1A2 and 10% CYP2C9).

Metabolism

Agomelatine is rapidly metabolised, mainly by the hepatic cytochrome P450 isoenzyme CYP1A2; the isoenzymes CYP2C9 and CYP2C19 also make a minor contribution. The major metabolites, hydroxylated and demethylated agomelatine, are not active and are rapidly conjugated and eliminated in the urine.

References

[1] zupancic m, guilleminault c. agomelatine. cns drugs, 2006, 20(12): 981-992.

Properties of Agomelatine

Melting point: 107-109°C
Boiling point: 478.8±28.0 °C(Predicted)
Density  1.109±0.06 g/cm3(Predicted)
storage temp.  2-8°C
solubility  DMSO: >50mg/mL
form  powder
pka 16.17±0.46(Predicted)
color  white to off-white
Merck  14,190
InChI InChI=1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17)
CAS DataBase Reference 138112-76-2(CAS DataBase Reference)

Safety information for Agomelatine

Signal word Warning
Pictogram(s)
ghs
Environment
GHS09
GHS Hazard Statements H400:Hazardous to the aquatic environment, acute hazard
Precautionary Statement Codes P273:Avoid release to the environment.

Computed Descriptors for Agomelatine

InChIKey YJYPHIXNFHFHND-UHFFFAOYSA-N
SMILES C(NCCC1=C2C(C=CC(OC)=C2)=CC=C1)(=O)C

Abamectin manufacturer

Nivika Chemo Pharma Pvt Ltd

1Y
Phone:+91-9824176501
Whatsapp: +91 9824176501
product: Agomelatine 99%
Inquiry

Darsh PharmaChem Pvt Ltd

1Y
Phone:+919712983850
Whatsapp: +91 9712983850
product: Agomelatine 99%
Inquiry

Viyash Life Sciences Pvt Ltd

1Y
Phone:+91-4023635052
product: 138112-76-2 Agomelatine 98%
Inquiry

Alembic Pharmaceuticals Limited

1Y
Phone:+912652280550
product: 138112-76-2 98%
Inquiry

Hetero Drugs Limited

1Y
Phone:+914023704923
product: Agomelatine 98%
Inquiry

Svak Life Sciences

1Y
Phone:+91-9705383777
Whatsapp: +91 9705383777
product: Agomelatine 138112-76-2 98%
Inquiry

Mehta API Pvt. Ltd.

1Y
Phone:+91-9920552082
Whatsapp: +91 9920552082
product: 138112-76-2 Agomelatine 98%
Inquiry

Ralington Pharma

1Y
Phone:+91-9687771722
Whatsapp: +91- 9687771722
product: 138112-76-2 98%
Inquiry

Biophore India Pharmaceuticals Pvt Ltd

1Y
Phone:+919030907714
Whatsapp: +91-9030907714
product: Agomelatine 98%
Inquiry

Related products of tetrahydrofuran

You may like

Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.